MedTrace Logo

Medication Adherence in Rheumatic Diseases

NCT06018350 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2025-09-09

Study results available
· View outcomes & findings →

Summary

The investigators will pilot test a clinician-led intervention to improve medication adherence in general rheumatology clinic across a spectrum of rheumatic diseases. The study will assess feasibility, acceptability, and fidelity, and explore signal for improved medication adherence.

Conditions

  • Chronic Rheumatic Diseases

Interventions

BEHAVIORAL

Clinician-led adherence intervention

The clinician will review real time pharmacy refill data during clinic and use effective communication techniques to discuss adherence with the patient

Sponsors & Collaborators

Principal Investigators

  • Kai Sun, MD, MS · Duke Health

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-02
Primary Completion
2024-06-05
Completion
2024-06-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06018350 on ClinicalTrials.gov